Royalty Pharma plc — Investor Relations & Filings

Royalty Pharma plc is the largest acquirer of biopharmaceutical royalties and a leading funder of innovation in the life sciences industry. The company's primary activity is purchasing royalty interests in approved and late-stage development biopharmaceutical products. This business model provides non-dilutive capital to academic institutions, research hospitals, and biotechnology and pharmaceutical companies. In exchange for this funding, Royalty Pharma receives a percentage of the future top-line sales of these therapies. The company manages a diversified portfolio of royalties on numerous commercially successful products across a wide range of therapeutic areas. Through tailored funding solutions, Royalty Pharma supports the advancement of new medicines and facilitates innovation throughout the biopharma ecosystem.